<http://webisa.webdatacommons.org/248268106>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<sec.gov> .
<http://webisa.webdatacommons.org/248268106>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/248268106>	<http://www.w3.org/ns/prov#value>	"develop products to treat addiction, including alcohol and opioid dependence that may compete with and negatively impact future sales of VIVITROL. Increased competition may lead to reduced unit sales" .
<http://webisa.webdatacommons.org/prov/438056269>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/248268106> .